Editorial
World J Gastroenterol
31(10):101838.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101838
Abstract (426)
|
Core Tip (490)
|
Full Article (HTML) (1899)
|
Full Article (PDF)-378K (128)
|
Full Article with Cover (PDF)-633K (116)
|
Full Article (XML)-71K (77)
|
Audio-3309K (20)
|
Peer-Review Report-245K (69)
|
Answering Reviewers-157K (75)
|
Received: 09/28/2024
|
Revised: 01/23/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (4068)
|
Similar Articles (152)
|
Timeline of Article Publication (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches
World J Gastroenterol
31(10):102289.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102289
Abstract (563)
|
Core Tip (471)
|
Full Article (HTML) (10023)
|
Figures (1-1) (455)
|
Tables (1-3) (453)
|
Full Article (PDF)-4025K (438)
|
Full Article with Cover (PDF)-4275K (221)
|
Full Article (XML)-507K (89)
|
Audio-1047K (31)
|
Peer-Review Report-271K (98)
|
Answering Reviewers-120K (106)
|
Received: 10/13/2024
|
Revised: 11/28/2024
|
Accepted: 01/17/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (9)
|
Total Visits (14621)
|
Similar Articles (333)
|
Timeline of Article Publication (14)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
World J Gastroenterol
31(10):103454.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103454
Abstract (391)
|
Core Tip (422)
|
Full Article (HTML) (2238)
|
Figures (1-1) (343)
|
Full Article (PDF)-1122K (130)
|
Full Article with Cover (PDF)-1376K (123)
|
Full Article (XML)-113K (77)
|
Audio-412K (17)
|
Peer-Review Report-223K (74)
|
Answering Reviewers-109K (64)
|
Received: 11/20/2024
|
Revised: 12/31/2024
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5406)
|
Similar Articles (1828)
|
Timeline of Article Publication (10)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Control Study
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
World J Gastroenterol
31(10):103716.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103716
Abstract (417)
|
Core Tip (473)
|
Full Article (HTML) (1896)
|
Figures (1-1) (334)
|
Tables (1-6) (319)
|
Full Article (PDF)-876K (114)
|
Full Article with Cover (PDF)-1130K (136)
|
Full Article (XML)-191K (83)
|
Audio-454K (25)
|
Peer-Review Report-229K (69)
|
Answering Reviewers-124K (59)
|
Supplementary Material-657K (73)
|
Received: 11/27/2024
|
Revised: 01/16/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5707)
|
Similar Articles (58)
|
Timeline of Article Publication (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Endoscopic full-thickness resection: A definitive solution for local complete resection of small rectal neuroendocrine neoplasms
World J Gastroenterol
31(10):100444.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100444
Abstract (440)
|
Core Tip (490)
|
Full Article (HTML) (1669)
|
Figures (1-4) (350)
|
Tables (1-3) (350)
|
Full Article (PDF)-8140K (189)
|
Full Article with Cover (PDF)-8392K (124)
|
Full Article (XML)-121K (76)
|
Audio-885K (34)
|
Peer-Review Report-197K (82)
|
Answering Reviewers-155K (97)
|
Supplementary Material-123K (66)
|
Received: 08/16/2024
|
Revised: 12/11/2024
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6219)
|
Similar Articles (18)
|
Timeline of Article Publication (11)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Gastroenterol
31(10):102393.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102393
Abstract (429)
|
Core Tip (506)
|
Full Article (HTML) (1650)
|
Figures (1-2) (372)
|
Tables (1-3) (347)
|
Full Article (PDF)-3168K (176)
|
Full Article with Cover (PDF)-3422K (143)
|
Full Article (XML)-97K (79)
|
Audio-586K (23)
|
Peer-Review Report-221K (107)
|
Answering Reviewers-311K (74)
|
Supplementary Material-128K (83)
|
Received: 10/16/2024
|
Revised: 01/04/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (7)
|
Total Visits (5600)
|
Similar Articles (3)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Circular RNA contributes to gastric cancer by targeting Wnt family member 2B as a competing endogenous RNA
World J Gastroenterol
31(10):99583.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.99583
Abstract (394)
|
Core Tip (442)
|
Full Article (HTML) (1355)
|
Figures (1-6) (330)
|
Full Article (PDF)-10367K (138)
|
Full Article with Cover (PDF)-10622K (136)
|
Full Article (XML)-108K (75)
|
Audio-200K (12)
|
Peer-Review Report-203K (78)
|
Answering Reviewers-316K (115)
|
Received: 10/23/2024
|
Revised: 12/26/2024
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (3875)
|
Similar Articles (1234)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Platelet activation relieves liver portal hypertension via the lymphatic system though the classical vascular endothelial growth factor receptor 3 signaling pathway
World J Gastroenterol
31(10):100194.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100194
Abstract (409)
|
Core Tip (402)
|
Full Article (HTML) (1823)
|
Figures (1-8) (396)
|
Full Article (PDF)-42475K (170)
|
Full Article with Cover (PDF)-42729K (144)
|
Full Article (XML)-113K (84)
|
Audio-352K (18)
|
Peer-Review Report-309K (65)
|
Answering Reviewers-116K (69)
|
Supplementary Material-190K (77)
|
Received: 08/09/2024
|
Revised: 12/16/2024
|
Accepted: 01/21/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (4706)
|
Similar Articles (143)
|
Timeline of Article Publication (12)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Lactococcus garvieae aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption
World J Gastroenterol
31(10):101014.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101014
Abstract (396)
|
Core Tip (452)
|
Full Article (HTML) (1706)
|
Figures (1-6) (333)
|
Tables (1-1) (365)
|
Full Article (PDF)-10815K (153)
|
Full Article with Cover (PDF)-11065K (140)
|
Full Article (XML)-143K (73)
|
Audio-400K (16)
|
Peer-Review Report-253K (65)
|
Answering Reviewers-98K (72)
|
Supplementary Material-270K (78)
|
Received: 09/03/2024
|
Revised: 12/19/2024
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5954)
|
Similar Articles (18)
|
Timeline of Article Publication (5)
|
Authors Evaluation (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
SEL1L-mediated endoplasmic reticulum associated degradation inhibition suppresses proliferation and migration in Huh7 hepatocellular carcinoma cells
World J Gastroenterol
31(10):103133.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103133
Abstract (448)
|
Core Tip (467)
|
Full Article (HTML) (1719)
|
Figures (1-7) (390)
|
Full Article (PDF)-9623K (153)
|
Full Article with Cover (PDF)-9876K (133)
|
Full Article (XML)-121K (76)
|
Audio-824K (16)
|
Peer-Review Report-275K (73)
|
Answering Reviewers-363K (84)
|
Supplementary Material-48K (61)
|
Received: 11/10/2024
|
Revised: 01/04/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4777)
|
Similar Articles (1807)
|
Timeline of Article Publication (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible?
World J Gastroenterol
31(10):100771.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100771
Abstract (393)
|
Core Tip (437)
|
Full Article (HTML) (930)
|
Figures (1-1) (362)
|
Tables (1-2) (362)
|
Full Article (PDF)-471K (96)
|
Full Article with Cover (PDF)-728K (69)
|
Full Article (XML)-61K (77)
|
Audio-512K (22)
|
Peer-Review Report-257K (60)
|
Answering Reviewers-156K (66)
|
Received: 08/25/2024
|
Revised: 01/10/2025
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3510)
|
Similar Articles (25)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102580.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102580
Abstract (487)
|
Core Tip (538)
|
Full Article (HTML) (1733)
|
Tables (1-1) (439)
|
Full Article (PDF)-370K (125)
|
Full Article with Cover (PDF)-625K (108)
|
Full Article (XML)-56K (78)
|
Audio-2970K (15)
|
Peer-Review Report-217K (67)
|
Answering Reviewers-149K (71)
|
Received: 10/22/2024
|
Revised: 01/16/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (4321)
|
Similar Articles (172)
|
Timeline of Article Publication (3)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102725.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102725
Abstract (456)
|
Core Tip (458)
|
Full Article (HTML) (3785)
|
Figures (1-1) (356)
|
Full Article (PDF)-1500K (172)
|
Full Article with Cover (PDF)-1754K (135)
|
Full Article (XML)-97K (76)
|
Audio-476K (26)
|
Peer-Review Report-468K (71)
|
Answering Reviewers-1818K (90)
|
Received: 10/27/2024
|
Revised: 01/16/2025
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (6477)
|
Similar Articles (280)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Treatment of intermediate-to-advanced unresectable hepatocellular carcinoma is shifting toward a multidisciplinary strategy that includes multiple modalities as needed
World J Gastroenterol
31(10):103420.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103420
Abstract (400)
|
Core Tip (443)
|
Full Article (HTML) (1807)
|
Figures (1-1) (321)
|
Tables (1-1) (359)
|
Full Article (PDF)-578K (117)
|
Full Article with Cover (PDF)-834K (124)
|
Full Article (XML)-91K (62)
|
Audio-833K (23)
|
Peer-Review Report-243K (61)
|
Answering Reviewers-100K (58)
|
Received: 11/18/2024
|
Revised: 01/31/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4561)
|
Similar Articles (1807)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):103973.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103973
Abstract (433)
|
Core Tip (477)
|
Full Article (HTML) (4006)
|
Full Article (PDF)-406K (266)
|
Full Article with Cover (PDF)-661K (165)
|
Full Article (XML)-95K (85)
|
Audio-989K (28)
|
Peer-Review Report-215K (60)
|
Answering Reviewers-118K (67)
|
Received: 12/05/2024
|
Revised: 01/24/2025
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (6382)
|
Similar Articles (3)
|
Timeline of Article Publication (2)
|
Authors Evaluation (4)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy
World J Gastroenterol
31(10):104429.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.104429
Abstract (427)
|
Core Tip (392)
|
Full Article (HTML) (1254)
|
Tables (1-1) (341)
|
Full Article (PDF)-366K (120)
|
Full Article with Cover (PDF)-621K (146)
|
Full Article (XML)-45K (76)
|
Audio-1658K (24)
|
Peer-Review Report-175K (58)
|
Answering Reviewers-38K (65)
|
Received: 12/19/2024
|
Revised: 01/13/2025
|
Accepted: 01/24/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3750)
|
Similar Articles (1859)
|
Timeline of Article Publication (3)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
